Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

• Biogen’s stock pops after earnings top estimates and company raises guidance

  Business - MarketWatch - 1 hour ago

• Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

  Business - CNBC - 1 hour ago

• Pfizer’s earnings crush estimates as company raises guidance

  Business - MarketWatch - 21 hours ago

• ABB Posts Higher Profit, Raises Margin Guidance

  Business - The Wall Street Journal - October 17

• Telia Raises Guidance After Key Metric Profit Beat

  Business - The Wall Street Journal - 6 days ago

• Southwest Airlines profit tops estimates, company expects higher revenue in fourth quarter

  Business - CNBC - 5 days ago

• Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales

  Business - CNBC - 19 hours ago

More from CNBC

• U.S. economy grew at a 2.8% pace in the third quarter, less than expected

  Business - CNBC - 32 minutes ago

• Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

  Business - CNBC - 1 hour ago

• Alphabet shares rise on earnings beats boosted by cloud revenue

  Business - CNBC - 4 hours ago

• Mortgage demand stalls as interest rates surge higher ahead of election

  Business - CNBC - 1 hour ago

• Volkswagen profit plunges 42% in third quarter amid sweeping overhaul plans

  Business - CNBC - 4 hours ago